AMH

anti-Mullerian hormone, the group of MicroRNA protein coding host genes|Receptor ligands|Transforming growth factor beta superfamily

Basic information

Region (hg38): 19:2249308-2252073

Links

ENSG00000104899NCBI:268OMIM:600957HGNC:464Uniprot:P03971AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • persistent Mullerian duct syndrome (Supportive), mode of inheritance: AR
  • persistent Mullerian duct syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Persistent Mullerian duct syndrome, type IAREndocrine; Oncologic; GenitourinaryIn males, recognition can allow surveillance and surgical explorations to correct manifestations such as cryptorchdisim, which can be important to preserve fertility and decrease the chance of related sequelae (eg, testicular tumors)Endocrine; Genitourinary; Oncologic8872466; 8895659; 11760020; 15878900; 18547961; 22188863

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AMH gene.

  • not provided (4 variants)
  • Persistent Mullerian duct syndrome (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
32
clinvar
7
clinvar
39
missense
1
clinvar
2
clinvar
68
clinvar
10
clinvar
5
clinvar
86
nonsense
3
clinvar
3
start loss
0
frameshift
2
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
2
non coding
3
clinvar
5
clinvar
8
Total 7 2 68 45 17

Highest pathogenic variant AF is 0.0000855

Variants in AMH

This is a list of pathogenic ClinVar variants found in the AMH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-2249337-G-A Inborn genetic diseases Conflicting classifications of pathogenicity (Feb 28, 2023)1909084
19-2249355-G-C Uncertain significance (Dec 01, 2023)3025681
19-2249357-C-A Inborn genetic diseases Uncertain significance (Nov 22, 2022)2329347
19-2249367-T-G AMH-related disorder Uncertain significance (Feb 21, 2024)381731
19-2249384-G-A Inborn genetic diseases Uncertain significance (Dec 05, 2022)2332934
19-2249385-C-T Likely benign (Nov 27, 2023)1545053
19-2249408-A-G Uncertain significance (Sep 24, 2021)1448481
19-2249423-G-T Inborn genetic diseases Uncertain significance (May 13, 2024)3292815
19-2249460-T-C Inborn genetic diseases Uncertain significance (Aug 26, 2022)2309123
19-2249461-G-A Likely benign (Jan 12, 2024)727144
19-2249468-C-G not specified Uncertain significance (Jun 01, 2024)2577293
19-2249469-C-A Inborn genetic diseases Uncertain significance (Dec 14, 2023)1362631
19-2249478-G-T Persistent Mullerian duct syndrome Benign (Jan 31, 2024)518296
19-2249482-AC-A Persistent Mullerian duct syndrome Pathogenic (Dec 22, 2019)1323119
19-2249498-C-T Likely benign (Oct 03, 2023)761241
19-2249506-A-G not specified Likely benign (May 22, 2019)1337165
19-2249512-C-T Likely benign (Apr 23, 2023)3023027
19-2249534-T-TC Pathogenic (Oct 28, 2016)372806
19-2249559-T-C Uncertain significance (Dec 01, 2023)3025536
19-2249564-G-A Uncertain significance (Feb 24, 2022)2073897
19-2249583-T-A Uncertain significance (Nov 16, 2021)1379979
19-2249583-T-C Inborn genetic diseases Uncertain significance (Feb 16, 2023)2485739
19-2249584-G-A Benign (Jan 29, 2024)1237409
19-2249605-C-T AMH-related disorder Likely benign (May 02, 2023)745907
19-2249612-C-T Inborn genetic diseases Uncertain significance (Dec 13, 2023)3115649

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AMHprotein_codingprotein_codingENST00000221496 52765
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.40e-120.01231249270391249660.000156
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.8813362941.140.00001943296
Missense in Polyphen143124.411.14951462
Synonymous-1.321631431.140.000009821330
Loss of Function-0.7011613.21.217.45e-7137

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007780.000592
Ashkenazi Jewish0.000.00
East Asian0.0001120.000109
Finnish0.0001920.000185
European (Non-Finnish)0.0001480.000133
Middle Eastern0.0001120.000109
South Asian0.0001020.0000980
Other0.0003420.000328

dbNSFP

Source: dbNSFP

Function
FUNCTION: This glycoprotein, produced by the Sertoli cells of the testis, causes regression of the Muellerian duct. It is also able to inhibit the growth of tumors derived from tissues of Muellerian duct origin.;
Disease
DISEASE: Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]: A form of male pseudohermaphroditism characterized by a failure of Muellerian duct regression in otherwise normal males. {ECO:0000269|PubMed:8162013, ECO:0000269|PubMed:8872466}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
TGF-beta signaling pathway - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);TGF-Core;Mesodermal Commitment Pathway;Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members;ALK2 signaling events (Consensus)

Haploinsufficiency Scores

pHI
0.346
hipred
N
hipred_score
0.220
ghis
0.438

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.768

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Amh
Phenotype
endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; neoplasm;

Zebrafish Information Network

Gene name
amh
Affected structure
spermatogonium
Phenotype tag
abnormal
Phenotype quality
increased amount

Gene ontology

Biological process
preantral ovarian follicle growth;urogenital system development;Mullerian duct regression;cell-cell signaling;gonadal mesoderm development;sex determination;sex differentiation;aging;regulation of signaling receptor activity;positive regulation of gene expression;response to organic cyclic compound;BMP signaling pathway;response to drug;positive regulation of NF-kappaB transcription factor activity;negative regulation of ovarian follicle development
Cellular component
extracellular region;extracellular space
Molecular function
signaling receptor binding;transforming growth factor beta receptor binding;hormone activity;growth factor activity